Lucid Diagnostics (LUCD) Profit After Tax (QoQ) (2020 - 2026)
Lucid Diagnostics (LUCD) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn |
| 10 | Lucid Diagnostics | 176.29 Mn | 142.89 Mn | 55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.98% |
| Mar 31, 2026 | 14.49% |
| Dec 31, 2025 | -56.45% |
| Sep 30, 2025 | -134.22% |
| Jun 30, 2025 | 83.50% |
| Mar 31, 2025 | -133.15% |
| Dec 31, 2024 | 6.71% |
| Sep 30, 2024 | -12.41% |
| Jun 30, 2024 | -3.70% |
| Mar 31, 2024 | 2.01% |
| Dec 31, 2023 | 23.78% |
| Sep 30, 2023 | -24.84% |
| Jun 30, 2023 | 29.95% |
| Mar 31, 2023 | -8.84% |
| Dec 31, 2022 | -4.04% |
| Sep 30, 2022 | 1.88% |
| Jun 30, 2022 | -19.19% |
| Mar 31, 2022 | -8.53% |
| Dec 31, 2021 | -62.51% |
| Sep 30, 2021 | -12.88% |